Michael H. Davidson

Insider Reports History

Entity
Individual
Location
Omthera Pharmaceuticals, Inc., 707 State Road, Princeton, NJ
Signature
/s/ Michael H. Davidson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael H. Davidson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Ordinary Shares 124K $3.15M $25.54 Jan 7, 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Warrant (right to buy) 85K $978K $11.50 Oct 9, 2024 Direct
CALADRIUS BIOSCIENCES, INC. Director Common Stock 210K $627K $2.99 Jan 10, 2022 Direct
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Option (right to buy) 670K Jan 6, 2025 Direct
TENAX THERAPEUTICS, INC. Director Stock Option (right to buy) 100K Dec 10, 2024 Direct
Silence Therapeutics plc Director Share Option (Right to Buy) 48K Jan 2, 2025 Direct
TENAX THERAPEUTICS, INC. Director Pre-Funded Warrant 47.5K Dec 10, 2024 Direct
BioAge Labs, Inc. Director Stock Option (Right to Buy) 34K Mar 26, 2024 Direct
TENAX THERAPEUTICS, INC. Director Warrant 25K Dec 10, 2024 Direct
Silence Therapeutics plc Director Ordinary Shares 13K Jan 2, 2025 Direct
TENAX THERAPEUTICS, INC. Director Common Stock 2.88K Dec 10, 2024 Direct

Insider Reports Filed by Michael H. Davidson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAMS NewAmsterdam Pharma Co N.V. Jan 6, 2025 2 $0 4 Jan 7, 2025 Chief Executive Officer, Director
SLN Silence Therapeutics plc Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
SLN Silence Therapeutics plc Jan 2, 2025 0 $0 3 Jan 2, 2025 Director
TENX TENAX THERAPEUTICS, INC. Dec 10, 2024 1 $0 4 Dec 12, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Oct 9, 2024 1 -$173K 4 Oct 11, 2024 Chief Executive Officer, Director
BIOA BioAge Labs, Inc. Sep 25, 2024 0 $0 3 Sep 25, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Aug 20, 2024 1 $81.4K 4 Aug 22, 2024 Chief Executive Officer, Director
TENX TENAX THERAPEUTICS, INC. Aug 8, 2024 3 $0 4 Aug 8, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Jun 20, 2024 1 $86.3K 4 Jun 24, 2024 Chief Executive Officer, Director
BIOA BioAge Labs, Inc. Mar 26, 2024 2 $0 4 Sep 27, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Jan 1, 2024 1 $0 4 Jan 3, 2024 Chief Executive Officer, Director
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3/A Jan 25, 2024 Chief Executive Officer, Director
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3 Dec 29, 2023 Chief Executive Officer, Director
TENX TENAX THERAPEUTICS, INC. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
LSTA CALADRIUS BIOSCIENCES, INC. Jan 10, 2022 1 $0 4 Jan 12, 2022 Director
TENX TENAX THERAPEUTICS, INC. Jun 11, 2021 3 $0 4 Jun 15, 2021 Director
TENX TENAX THERAPEUTICS, INC. Feb 25, 2021 0 $0 3 Jun 15, 2021 Director